Can Healthcare Withstand Hacking? 

Over the past year, cybersecurity attacks have occurred at an alarming rate. Due to a combination of employees working from home and the general chaos of the pandemic, hackers took advantage, and there were some high-profile attacks, such as the Colonial pipeline.
 
But why is the healthcare industry particularly vulnerable? 
 
Here to give insights on this episode of Full Circle Healthcare is David Macfarlane, Marketing and Communications Manager at Medsphere. He talked with Host Courtney Echerd about what is causing increased cyberattacks and how the healthcare industry can withstand the increase in hacking. 
 
“We know the threat is more than significant,” Macfarlane said. “It has really ramped up a lot in recent years.”
 
While it’s difficult to put numbers to it, as it’s not effectively recorded right now in every single instance, according to Macfarlane. Healthcare organizations don’t necessarily want to report a hack because it’s terrible PR. But, for the numbers currently recorded, there is a ransomware attack on a business in the United States every eight minutes. 
 
But what makes the healthcare industry, in particular, so vulnerable? Old hardware, Macfarlane said. 
 

“We’ve got a situation where about 75 percent of healthcare organizations are operating on hardware that no longer receives patches, so they’re not getting their security updates,” Macfarlane said. “That makes healthcare the most vulnerable sector of the economy.

Follow us on social media for the latest updates in B2B!

Twitter – @MarketScale
Facebook – facebook.com/marketscale
LinkedIn – linkedin.com/company/marketscale

Recent Episodes

In this impactful episode of the ConCensis podcast, host Yasmeen Hassan sits down with Robby Miller, Sterile Processing Manager at St. Joseph’s Hospital Medical Center, to explore how artificial intelligence is revolutionizing the field of sterile processing. With nearly 30 years of experience in healthcare, Miller shares his journey from EMT to SPD leader, offering…

In the last two decades, oncology has undergone a transformation with over 300 new cancer therapies approved by the FDA—many offering novel mechanisms of action. Despite these innovations, resistance to treatment remains a critical challenge, with cancer cells evolving or adapting to evade even the most advanced therapeutics. This issue is particularly pressing given that…

In an era where precision and predictability define the future of oncology, organoid technology is emerging as a transformative tool in drug discovery. These miniature, lab-grown 3D tissues mirror real human biology more closely than traditional 2D models or even animal systems, offering researchers the potential to predict patient-specific drug responses. As organoids become more…